Publication | Closed Access

Activity of two phase I drugs N-methylformamide (NSC-3051) and Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assay

Human TumorsTumor BiologyMedicinal ChemistryUrologySurgical OncologyOncologyMedicineDrugs N-methylformamidePharmacotherapyFresh Surgical ExplantsAnti-cancer AgentCancer TreatmentPharmacologyCancer Research